Literature DB >> 15323136

Critical values in surgical pathology.

Telma C Pereira1, Yulin Liu, Jan F Silverman.   

Abstract

Analogous to critical values (CVs) in clinical pathology, occasional diagnoses in surgical pathology could require immediate contact of the physician to rapidly initiate treatment. However, there are no established CV guidelines in surgical pathology. We studied the incidence of CVs in surgical pathology by retrospective review of 2,659 surgical pathology reports and surveyed the perceptions of 5 clinicians and 11 pathologists about CVs in surgical pathology. We identified 13 CV cases (0.49%); 4 of the 13 reports documented phone calls to the clinician (most at least 1 day before final sign-out), and in 2 other reports the requisition included clinical history that implied previous knowledge of the diagnosis. The survey results indicated that for most diagnoses there was a range of opinions about whether immediate treatment was necessary and the need for a stat phone call. CVs occur in surgical pathology, but often there is no documented phone call in the surgical pathology report. Because there is little agreement about which diagnoses require a phone call and the degree of urgency, a consensus conference might prove useful for establishing surgical pathology CV guidelines and could represent a practice improvement.

Mesh:

Year:  2004        PMID: 15323136     DOI: 10.1309/7NRW-7G68-4VEP-WPMR

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

Review 1.  Pathology consultation on reporting of critical values.

Authors:  Jonathan R Genzen; Christopher A Tormey
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

2.  Critical Diagnoses in Ophthalmic Pathology: Suspected Important Unanticipated Diagnoses in Surgically Removed Eyes.

Authors:  Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2019-06-12

3.  How do surgical pathologists evaluate critical diagnoses (critical values)?

Authors:  Masoud Mireskandari
Journal:  Diagn Pathol       Date:  2008-07-12       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.